Cargando…
Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Respiratory RNA viruses are constantly evolving, thus requiring development of additional prophylactic and therapeutic strategies. Harnessing the innate immune system to non-specifically respond to viral infection has the advantage of being able to circumvent viral mutations that render the virus re...
Autores principales: | Christopher, ME, Wong, JP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552307/ http://dx.doi.org/10.2174/187152111800194434 |
Ejemplares similares
-
Activation of toll-like receptor signaling pathway for protection against influenza virus infection
por: Wong, J.P., et al.
Publicado: (2009) -
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
por: Girkin, Jason L.N., et al.
Publicado: (2022) -
The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013) -
Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020) -
Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)